{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:03:32Z","timestamp":1789513412376,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific Research and Cultivation Fund of Shandong Provincial Third Hospital","award":["M2023005"],"award-info":[{"award-number":["M2023005"]}]},{"DOI":"10.13039\/501100019446","name":"Medical and Health Science and Technology Development Project of Shandong Province","doi-asserted-by":"publisher","award":["202304050369"],"award-info":[{"award-number":["202304050369"]}],"id":[{"id":"10.13039\/501100019446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-58396-z","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:56:08Z","timestamp":1782208568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A H-MnO2 nanoplatform for tumor microenvironment remodeling and multimodal synergistic therapy in prostate cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Heng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deqi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixiao","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maokun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8002-0156","authenticated-orcid":false,"given":"Yunji","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"6","key":"58396_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68(6), 394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492 (2018).","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"58396_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen, W. et al. Cancer statistics in China, 2015. CA Cancer J. Clin. 66(2), 115\u201332. https:\/\/doi.org\/10.3322\/caac.21338 (2016).","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"58396_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2174\/15680266196661901-25145836","volume":"19","author":"J Zhang","year":"2019","unstructured":"Zhang, J. et al. Nanoparticle therapy for prostate cancer: overview and perspectives. Curr. Top. Med. Chem. 19(1), 57\u201373. https:\/\/doi.org\/10.2174\/15680266196661901-25145836 (2019) (PMID: 30686255).","journal-title":"Curr. Top. Med. Chem."},{"issue":"5","key":"58396_CR4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.6004\/jnccn.2019.0023","volume":"17","author":"JL Mohler","year":"2019","unstructured":"Mohler, J. L. et al. Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Canc. Netw. 17(5), 479\u2013505. https:\/\/doi.org\/10.6004\/jnccn.2019.0023 (2019).","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"23","key":"58396_CR5","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.635144","volume":"114","author":"D Cardinale","year":"2006","unstructured":"Cardinale, D. et al. Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. Circulation. 114(23), 2474\u201381. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.635144 (2006) (Epub 2006 Nov 13 PMID: 17101852).","journal-title":"Circulation."},{"issue":"6","key":"58396_CR6","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/cmdc.201200052","volume":"7","author":"P Zhao","year":"2012","unstructured":"Zhao, P. & Astruc, D. Docetaxel nanotechnology in anticancer therapy. ChemMedChem. 7(6), 952\u201372. https:\/\/doi.org\/10.1002\/cmdc.201200052 (2012) (Epub 2012 Apr 19 PMID: 22517723).","journal-title":"ChemMedChem."},{"issue":"3","key":"58396_CR7","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s12033-010-9321-2","volume":"46","author":"BC Baguley","year":"2010","unstructured":"Baguley, B. C. Multiple drug resistance mechanisms in cancer. Mol Biotechnol. 46(3), 308\u201316. https:\/\/doi.org\/10.1007\/s12033-010-9321-2 (2010) (PMID: 20717753).","journal-title":"Mol Biotechnol."},{"issue":"5","key":"58396_CR8","first-page":"1964","volume":"61","author":"Y Urasaki","year":"2001","unstructured":"Urasaki, Y. et al. Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line. Cancer Res. 61(5), 1964\u20139 (2001) (PMID: 11280753).","journal-title":"Cancer Res."},{"issue":"1-2","key":"58396_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.drup.2014.04.001","volume":"17","author":"A Ganju","year":"2014","unstructured":"Ganju, A. et al. Nanoways to overcome docetaxel resistance in prostate cancer. Drug Resist. Updates 17(1\u20132), 13\u201323. https:\/\/doi.org\/10.1016\/j.drup.2014.04.001 (2014).","journal-title":"Drug Resist. Updates"},{"key":"58396_CR10","doi-asserted-by":"publisher","unstructured":"Liu Y, Wu W, Wang Y, Han S, Yuan Y, Huang J, Shuai X, Peng Z. Recent development of gene therapy for pancreatic cancer using non-viral nanovectors. Biomater Sci. 9(20):6673-6690. https:\/\/doi.org\/10.1039\/d1bm00748c. Erratum in: Bioma ter Sci. 9(20):6966-6969. 10.1039\/d1bm90082j. PMID: 34378568 (2021).","DOI":"10.1039\/d1bm00748c"},{"issue":"5","key":"58396_CR11","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7150\/jca.17648.PMID:28382138;PMCID:PMC5381164","volume":"8","author":"M Wang","year":"2017","unstructured":"Wang, M. et al. Role of tumor microenvironment in tumorigenesis. J Cancer. 8(5), 761\u2013773. https:\/\/doi.org\/10.7150\/jca.17648.PMID:28382138;PMCID:PMC5381164 (2017).","journal-title":"J Cancer."},{"issue":"2 Pt A","key":"58396_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.canlet.2014.01.032","volume":"356","author":"W Zeng","year":"2015","unstructured":"Zeng, W., Liu, P., Pan, W., Singh, S. R. & Wei, Y. Hypoxia and hypoxia inducible factors in tumor metabolism. Cancer Lett. 356(2 Pt A), 263\u20137. https:\/\/doi.org\/10.1016\/j.canlet.2014.01.032 (2015).","journal-title":"Cancer Lett."},{"issue":"1","key":"58396_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.canlet.2015.07.039","volume":"368","author":"L Hui","year":"2015","unstructured":"Hui, L. & Chen, Y. Tumor microenvironment: Sanctuary of the devil. Cancer Lett. 368(1), 7\u201313. https:\/\/doi.org\/10.1016\/j.canlet.2015.07.039 (2015) (Epub 2015 Aug 11 PMID: 26276713).","journal-title":"Cancer Lett."},{"issue":"27","key":"58396_CR14","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1002\/adma.201300929","volume":"25","author":"J Wang","year":"2013","unstructured":"Wang, J. et al. Tumor redox heterogeneity-responsive prodrug nanocapsules for cancer chemotherapy. Adv Mater. 25(27), 3670\u20136. https:\/\/doi.org\/10.1002\/adma.201300929 (2013) (Epub 2013 Jun 6 PMID: 23740675).","journal-title":"Adv Mater."},{"issue":"2","key":"58396_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jconrel.2012.12.013","volume":"166","author":"S Naahidi","year":"2013","unstructured":"Naahidi, S. et al. Biocompatibility of engineered nanoparticles for drug delivery. J. Control Release. 166(2), 182\u201394. https:\/\/doi.org\/10.1016\/j.jconrel.2012.12.013 (2013) (Epub 2012 Dec 20 PMID: 23262199).","journal-title":"J. Control Release."},{"issue":"11","key":"58396_CR16","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41571-020-0410-2","volume":"17","author":"X Li","year":"2020","unstructured":"Li, X., Lovell, J. F., Yoon, J. & Chen, X. Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat. Rev. Clin. Oncol. 17(11), 657\u2013674. https:\/\/doi.org\/10.1038\/s41571-020-0410-2 (2020) (Epub 2020 Jul 22 PMID: 32699309).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"39","key":"58396_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201901778","volume":"31","author":"B Yang","year":"2019","unstructured":"Yang, B., Chen, Y. & Shi, J. Nanocatalytic medicine. Adv. Mater. 31(39), e1901778. https:\/\/doi.org\/10.1002\/adma.201901778 (2019).","journal-title":"Adv. Mater."},{"issue":"13","key":"58396_CR18","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1039\/d4tb00008k","volume":"12","author":"XX Lu","year":"2024","unstructured":"Lu, X. X., Xue, C., Dong, J. H., Zhang, Y. Z. & Gao, F. Nanoplatform-based strategies for enhancing the lethality of current antitumor PDT. J. Mater. Chem. B. 12(13), 3209\u20133225. https:\/\/doi.org\/10.1039\/d4tb00008k (2024) (PMID: 38497405).","journal-title":"J. Mater. Chem. B."},{"issue":"6","key":"58396_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrm3801","volume":"15","author":"KM Holmstr\u00f6m","year":"2014","unstructured":"Holmstr\u00f6m, K. M. & Finkel, T. Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat Rev Mol Cell Biol. 15(6), 411\u201321. https:\/\/doi.org\/10.1038\/nrm3801 (2014) (PMID: 24854789).","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"7047","key":"58396_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nature03688.PMID:16001073;PMCID:PMC2784913","volume":"436","author":"DC Radisky","year":"2005","unstructured":"Radisky, D. C. et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature. 436(7047), 123\u20137. https:\/\/doi.org\/10.1038\/nature03688.PMID:16001073;PMCID:PMC2784913 (2005).","journal-title":"Nature."},{"issue":"18","key":"58396_CR21","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1182\/blood-2011-10-385658","volume":"119","author":"M Nieborowska-Skorska","year":"2012","unstructured":"Nieborowska-Skorska, M. et al. Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors. Blood 119(18), 4253\u201363. https:\/\/doi.org\/10.1182\/blood-2011-10-385658 (2012).","journal-title":"Blood"},{"key":"58396_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2020.100946","volume":"35","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Recent progress of chemodynamic therapy-induced combination cancer therapy[J]. Nano Today 35, 100946 (2020).","journal-title":"Nano Today"},{"issue":"6","key":"58396_CR23","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1002\/anie.201510031","volume":"55","author":"C Zhang","year":"2016","unstructured":"Zhang, C. et al. Synthesis of iron nanometallic glasses and their application in cancer therapy by a localized fenton reaction. Angew Chem. Int. Ed. Engl. 55(6), 2101\u20136. https:\/\/doi.org\/10.1002\/anie.201510031 (2016) (Epub 2016 Jan 6 PMID: 26836344).","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"58396_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.120710","volume":"271","author":"L Deng","year":"2021","unstructured":"Deng, L. et al. Low-intensity focused ultrasound-augmented Cascade chemodynamic therapy via boosting ROS generation. Biomaterials. 271, 120710. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.120710 (2021) (Epub 2021 Feb 9 PMID: 33610047).","journal-title":"Biomaterials."},{"issue":"5","key":"58396_CR25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","volume":"22","author":"EC Cheung","year":"2022","unstructured":"Cheung, E. C. & Vousden, K. H. The role of ROS in tumour development and progression. Nat. Rev. Cancer. 22(5), 280\u2013297. https:\/\/doi.org\/10.1038\/s41568-021-00435-0 (2022) (Epub 2022 Jan 31 PMID: 35102280).","journal-title":"Nat. Rev. Cancer."},{"issue":"1","key":"58396_CR26","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41467-017-00424-8.PMID:28842577;PMCID:PMC5572465","volume":"8","author":"M Huo","year":"2017","unstructured":"Huo, M., Wang, L., Chen, Y. & Shi, J. Tumor-selective catalytic nanomedicine by nanocatalyst delivery. Nat. Commun. 8(1), 357. https:\/\/doi.org\/10.1038\/s41467-017-00424-8.PMID:28842577;PMCID:PMC5572465 (2017).","journal-title":"Nat. Commun."},{"issue":"11","key":"58396_CR27","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3390\/biom9110735.PMID:31766246;PMCID:PMC6920770","volume":"9","author":"V Aggarwal","year":"2019","unstructured":"Aggarwal, V. et al. Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements. Biomolecules. 9(11), 735. https:\/\/doi.org\/10.3390\/biom9110735.PMID:31766246;PMCID:PMC6920770 (2019).","journal-title":"Biomolecules."},{"issue":"33","key":"58396_CR28","doi-asserted-by":"publisher","first-page":"7129","DOI":"10.1002\/adma.201601902","volume":"28","author":"Q Chen","year":"2016","unstructured":"Chen, Q. et al. Intelligent albumin-MnO2 nanoparticles as pH-\/H2O2-responsive dissociable nanocarriers to modulate tumor hypoxia for effective combination therapy. Adv. Mater. 28(33), 7129\u201336. https:\/\/doi.org\/10.1002\/adma.201601902 (2016).","journal-title":"Adv. Mater."},{"issue":"6","key":"58396_CR29","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1039\/c9nr10939k","volume":"12","author":"Z Chen","year":"2020","unstructured":"Chen, Z. et al. A non-surfactant self-templating strategy for mesoporous silica nanospheres: beyond the St\u00f6ber method. Nanoscale 12(6), 3657\u20133662. https:\/\/doi.org\/10.1039\/c9nr10939k (2020).","journal-title":"Nanoscale"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58396-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58396-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58396-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:30:55Z","timestamp":1789511455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58396-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["58396"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-58396-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was reported in accordance with ARRIVE guidelines.The experiments were approved by the Ethical Committee of Shandong Provincial Third Hospital (No. DWKYLL-2024004).","order":2,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"28784"}}